| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
428 |
280 |
$63K |
| 92551 |
|
37 |
34 |
$0.00 |
| 3074F |
|
271 |
185 |
$0.00 |
| 1036F |
|
302 |
199 |
$0.00 |
| 1125F |
|
234 |
158 |
$0.00 |
| 99384 |
|
34 |
27 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
242 |
170 |
$0.00 |
| 96127 |
|
332 |
217 |
$0.00 |
| 3008F |
|
595 |
266 |
$0.00 |
| 85018 |
|
48 |
42 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
206 |
125 |
$0.00 |
| 1126F |
|
71 |
58 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
17 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
48 |
36 |
$0.00 |
| 3078F |
|
246 |
165 |
$0.00 |
| 99173 |
|
37 |
34 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
35 |
28 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
130 |
99 |
$0.00 |
| 81003 |
|
37 |
34 |
$0.00 |